Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 23, 2025 04:04 ET | Source: Research and Markets

Prostate-Specific Membrane Antigen (PSMA) Targeted Therapy Pipeline Review 2025 Tracks Drug Candidates for Prostate Cancer

Dublin, April 23, 2025 (GLOBE NEWSWIRE) -- The "PSMA - Targeted Therapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This report provides information on approved...
March 04, 2025 10:49 ET | Source: Research and Markets

Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Pipeline Market Research 2025: Global Advancements Poised to Transform Oncology Landscape

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Chimeric Antigen Receptor T-Cell Therapy (CAR-T) - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. The Chimeric...
October 24, 2024 10:15 ET | Source: Research and Markets

Mesothelin-Targeted Immunotherapy Pipeline Market Review 2024: Drug Code/INN, Target(s)/MoA, Class of Compound, Territory of Main Competitor, Indication(s) & R&D Stage

Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Mesothelin-Targeted Immunotherapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This product provides basic...
October 24, 2024 10:01 ET | Source: Research and Markets

PSMA Targeted Therapy Pipeline Review 2024: Drug Code/INN, Target(s)/MoA, Class of Compound, Territory of Main Competitor, Indication(s) & R&D Stage

Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "PSMA - Targeted Therapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This product provides basic information on...
July 01, 2024 07:54 ET | Source: Research and Markets

Advanced Liver Cancer Therapeutics Research 2024: Comprehensive Insights About 50+ Companies and 50+ Pipeline Drugs - Product Type, Stage, Route of Administration, and Molecule Type

Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Advanced liver cancer - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Advanced liver cancer -...